Organon Pharma Indonesia Tbk. vs Triniti Dinamik Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Triniti Dinamik Tbk. trades at Rp50 (market cap 378.56B). The key difference: Triniti Dinamik Tbk. is far larger — about 3.6× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | TRUE | |
|---|---|---|
Market Cap | 104.4B | 378.56B |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Triniti Dinamik Tbk. (the Company) was established based on Notarial Deed No. 08 dated December 13, 2013, which was made by Notary Herna Gunawan, SH.,M.Kn., a Notary in Jakarta.
Read more on TRUE →